Quick summary
Chromium picolinate is a chemical form of the essential trace mineral chromium. Chromium itself plays a role in macronutrient metabolism and glucose regulation. Chromium picolinate is a commonly used supplement form believed to enhance chromium bioavailability.
What is it?
Chromium picolinate is a synthetic compound consisting of trivalent chromium chelated to three picolinic acid molecules. It is one of several chromium forms used in dietary supplements to increase chromium intake. Chromium is an essential trace mineral that exists naturally in various foods but often in very small amounts. While chromium picolinate is a man-made form designed to improve absorption, it provides chromium, which participates in normal metabolic processes.
Main functions in the body
- Chromium is involved in the metabolism of carbohydrates, fats, and proteins.
- It plays a role in the regulation of blood glucose by enhancing insulin action.
Recommended intake and upper limit
The National Institutes of Health (NIH) provides recommendations for chromium intake as chromium in general; specific guidelines for chromium picolinate are not established. Intake needs vary by age, sex, and life stage, and no official Recommended Dietary Allowance (RDA) or Adequate Intake (AI) values have been universally set.
No tolerable upper intake level (UL) has been established for chromium picolinate or chromium due to insufficient data.
Source: NIH Office of Dietary Supplements – Chromium
Best food sources
Chromium is naturally present in various foods, although levels can vary widely depending on soil content and food processing. Common dietary sources of chromium include:
- Whole grains
- Broccoli
- Green beans
- Meat
Chromium picolinate itself is not found in food; it is a synthetic form used in supplements to potentially improve chromium uptake.
Deficiency: causes, symptoms and risk groups
Chromium deficiency is rare in the general population and typically occurs only under specific medical conditions, such as prolonged intravenous feeding without chromium supplementation.
Risk groups:
- Individuals with inadequate dietary chromium intake
- People receiving long-term total parenteral nutrition without chromium added
Signs and symptoms of deficiency may include:
- Impaired glucose tolerance
- Peripheral neuropathy
Chromium deficiency has been mainly documented in clinical settings rather than in apparently healthy individuals.
Supplement forms
Chromium picolinate is one of several supplement forms of chromium. It is popular due to its proposed higher bioavailability compared to other chemical forms such as chromium chloride.
Absorption and bioavailability
Chromium picolinate demonstrates better absorption compared to some other chromium salts, including chromium chloride. However, chromium absorption from supplements is generally low and variable.
No specific enhancers or inhibitors of chromium picolinate absorption have been clearly identified in available research.
Potential benefits: what does the evidence say?
Glucose metabolism
Some small and mixed human clinical trials have investigated chromium picolinate supplementation for improving glycemic control in people with glucose intolerance or type 2 diabetes. The results have been inconsistent, with some studies showing modest benefits and others reporting no significant effects.
Limitations of the evidence include small sample sizes, variable study designs, and methodological weaknesses. Overall, evidence is limited and inconclusive regarding chromium picolinate’s role in improving blood glucose regulation in people without chromium deficiency.
Side effects and toxicity
Chromium picolinate supplementation is generally well tolerated at usual supplemental doses. Clinically relevant side effects are uncommon, but data on long-term safety and toxicity are limited.
No official tolerable upper intake level (UL) is established for chromium picolinate due to insufficient evidence, so caution is advised with high-dose supplementation.
Drug and nutrient interactions
No specific drug or nutrient interactions with chromium picolinate have been clearly documented in available evidence. However, individuals using medications or with existing health conditions should consult a healthcare professional before supplementing.
Who should be careful?
People who are pregnant, breastfeeding, have medical conditions including kidney disease, thyroid disease, iron overload disorders, or who use medications should consult a healthcare provider before using chromium picolinate supplements. Given the limited data on safety and lack of established upper limits, cautious use is recommended.
Frequently asked questions
- Is chromium picolinate better absorbed than other forms? Chromium picolinate appears to have better absorption compared to some other forms like chromium chloride, but absorption remains generally low.
- Can chromium picolinate help manage blood sugar? Some research suggests possible benefits for people with impaired glucose metabolism, but the evidence is limited and inconsistent.
- Is chromium deficiency common? Chromium deficiency is rare and mostly occurs in clinical settings such as long-term intravenous feeding without chromium.
- Are there any risks with taking chromium picolinate? At typical doses, chromium picolinate is usually well tolerated, but high doses or long-term use should be approached cautiously.
Evidence limitations
- Lack of large, well-designed randomized controlled trials on chromium picolinate supplementation.
- Insufficient evidence to establish clear benefits or to define safety margins beyond correction of deficiency.
- EU authorized health claims are not currently supplied for chromium picolinate supplements.
References
Disclaimer
This information is provided for general knowledge and educational purposes. It is not a substitute for professional medical advice, diagnosis, or treatment. Individuals considering chromium picolinate supplements should consult with a qualified healthcare professional, especially if pregnant, breastfeeding, having medical conditions, or taking medications.
Last reviewed
June 2024